
Thai N. Pham
Examiner (ID: 11011, Phone: (571)270-5518 , Office: P/2844 )
| Most Active Art Unit | 2844 |
| Art Unit(s) | 2844, 2821, 4134 |
| Total Applications | 1345 |
| Issued Applications | 1066 |
| Pending Applications | 85 |
| Abandoned Applications | 219 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13371681
[patent_doc_number] => 20180237381
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => COMPOSITION AND METHODS OF USE OF NOVEL PHENYLALANINE SMALL ORGANIC COMPOUNDS TO DIRECTLY MODULATE PCSK9 PROTEIN ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 15/753768
[patent_app_country] => US
[patent_app_date] => 2016-08-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14443
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 107
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15753768
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/753768 | Composition and methods of use of novel phenylalanine small organic compounds to directly modulate PCSK9 protein activity | Aug 18, 2016 | Issued |
Array
(
[id] => 16169710
[patent_doc_number] => 10711261
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-14
[patent_title] => Tethering cysteine residues using cyclic disulfides
[patent_app_type] => utility
[patent_app_number] => 15/753319
[patent_app_country] => US
[patent_app_date] => 2016-08-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12567
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 223
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15753319
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/753319 | Tethering cysteine residues using cyclic disulfides | Aug 16, 2016 | Issued |
Array
(
[id] => 13763331
[patent_doc_number] => 10174000
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-01-08
[patent_title] => Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators
[patent_app_type] => utility
[patent_app_number] => 15/754650
[patent_app_country] => US
[patent_app_date] => 2016-08-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38501
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15754650
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/754650 | Bicyclic-fused heteroaryl or aryl compounds as IRAK4 modulators | Aug 15, 2016 | Issued |
Array
(
[id] => 11127854
[patent_doc_number] => 20160324828
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-11-10
[patent_title] => 'INDOLE AMIDE DERIVATIVES AND RELATED COMPOUNDS FOR USE IN THE TREATMENT OF NEURODEGENERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/215750
[patent_app_country] => US
[patent_app_date] => 2016-07-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 104210
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15215750
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/215750 | Indole amide derivatives and related compounds for use in the treatment of neurodegenerative diseases | Jul 20, 2016 | Issued |
Array
(
[id] => 15573909
[patent_doc_number] => 10577321
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Deoxyuridine triphosphatase inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/740783
[patent_app_country] => US
[patent_app_date] => 2016-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32807
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15740783
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/740783 | Deoxyuridine triphosphatase inhibitors | Jul 6, 2016 | Issued |
Array
(
[id] => 13196009
[patent_doc_number] => 10112914
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-30
[patent_title] => Polymorphs of a mPGES-1 inhibiting triazolone compound
[patent_app_type] => utility
[patent_app_number] => 15/573387
[patent_app_country] => US
[patent_app_date] => 2016-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 7
[patent_no_of_words] => 11925
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 7
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15573387
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/573387 | Polymorphs of a mPGES-1 inhibiting triazolone compound | Jun 12, 2016 | Issued |
Array
(
[id] => 16429373
[patent_doc_number] => 10829440
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-10
[patent_title] => Antibacterial compounds and methods of making and using same
[patent_app_type] => utility
[patent_app_number] => 15/570923
[patent_app_country] => US
[patent_app_date] => 2016-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 12
[patent_no_of_words] => 26218
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15570923
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/570923 | Antibacterial compounds and methods of making and using same | Jun 9, 2016 | Issued |
Array
(
[id] => 11326170
[patent_doc_number] => 20160356782
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-08
[patent_title] => 'FLUOROGENIC HYDRAZINE-SUBSTITUTED COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/176872
[patent_app_country] => US
[patent_app_date] => 2016-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 20868
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 13
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15176872
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/176872 | Fluorogenic hydrazine-substituted compounds | Jun 7, 2016 | Issued |
Array
(
[id] => 11082141
[patent_doc_number] => 20160279106
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-29
[patent_title] => 'THERAPEUTIC OR PROPHYLACTIC AGENT FOR TUMOR LYSIS SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 15/172698
[patent_app_country] => US
[patent_app_date] => 2016-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 4971
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15172698
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/172698 | THERAPEUTIC OR PROPHYLACTIC AGENT FOR TUMOR LYSIS SYNDROME | Jun 2, 2016 | Abandoned |
Array
(
[id] => 11071551
[patent_doc_number] => 20160268515
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-15
[patent_title] => 'TRIAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE WITH THE USE OF TRIAZOLE DERIVATIVE'
[patent_app_type] => utility
[patent_app_number] => 15/161568
[patent_app_country] => US
[patent_app_date] => 2016-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 58
[patent_figures_cnt] => 58
[patent_no_of_words] => 36379
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15161568
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/161568 | Triazole derivative, and light-emitting element, light-emitting device, and electronic device with the use of triazole derivative | May 22, 2016 | Issued |
Array
(
[id] => 14102253
[patent_doc_number] => 20190092802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-28
[patent_title] => ANTAGONISTS OF NK1 RECEPTORS DERIVED FROM CARBOHYDRATES, PRODUCTION METHOD AND MEDICAL USE
[patent_app_type] => utility
[patent_app_number] => 15/577150
[patent_app_country] => US
[patent_app_date] => 2016-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11914
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15577150
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/577150 | ANTAGONISTS OF NK1 RECEPTORS DERIVED FROM CARBOHYDRATES, PRODUCTION METHOD AND MEDICAL USE | May 19, 2016 | Abandoned |
Array
(
[id] => 11497735
[patent_doc_number] => 20170071919
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-03-16
[patent_title] => 'Pyridine and Pyrazine derivative for the Treatment of CF'
[patent_app_type] => utility
[patent_app_number] => 15/156528
[patent_app_country] => US
[patent_app_date] => 2016-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 39541
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15156528
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/156528 | Pyridine and pyrazine derivative for the treatment of CF | May 16, 2016 | Issued |
Array
(
[id] => 15395743
[patent_doc_number] => 10538515
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-21
[patent_title] => Isatin-derived compounds, use of the compounds for the treatment of AIDS and method of treatment using these compounds
[patent_app_type] => utility
[patent_app_number] => 16/099901
[patent_app_country] => US
[patent_app_date] => 2016-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10609
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16099901
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/099901 | Isatin-derived compounds, use of the compounds for the treatment of AIDS and method of treatment using these compounds | May 9, 2016 | Issued |
Array
(
[id] => 11401635
[patent_doc_number] => 20170022174
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-01-26
[patent_title] => 'COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES'
[patent_app_type] => utility
[patent_app_number] => 15/151409
[patent_app_country] => US
[patent_app_date] => 2016-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 28927
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15151409
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/151409 | COMPOUNDS FOR THE TREATMENT OF NEURODEGENERATIVE DISEASES | May 9, 2016 | Abandoned |
Array
(
[id] => 12042906
[patent_doc_number] => 09820486
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-21
[patent_title] => 'Compositions and methods for controlling nematodes'
[patent_app_type] => utility
[patent_app_number] => 15/147247
[patent_app_country] => US
[patent_app_date] => 2016-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21818
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 32
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15147247
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/147247 | Compositions and methods for controlling nematodes | May 4, 2016 | Issued |
Array
(
[id] => 13457695
[patent_doc_number] => 20180280390
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-10-04
[patent_title] => Heteroaryl-Pyrimidinone Compounds as PDE2 Inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/571192
[patent_app_country] => US
[patent_app_date] => 2016-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 26031
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15571192
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/571192 | Heteroaryl-pyrimidinone compounds as PDE2 inhibitors | May 1, 2016 | Issued |
Array
(
[id] => 11045119
[patent_doc_number] => 20160242076
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'APPARATUS AND METHOD OF REPORTING LOGGED MEASUREMENT IN WIRELESS COMMUNICATION SYSTEM'
[patent_app_type] => utility
[patent_app_number] => 15/139652
[patent_app_country] => US
[patent_app_date] => 2016-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 7473
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15139652
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/139652 | Apparatus and method of reporting logged measurement in wireless communication system | Apr 26, 2016 | Issued |
Array
(
[id] => 11602435
[patent_doc_number] => 20170119734
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-05-04
[patent_title] => 'TETRAZOLONES AS INHIBITORS OF FATTY ACID SYNTHASE'
[patent_app_type] => utility
[patent_app_number] => 15/136817
[patent_app_country] => US
[patent_app_date] => 2016-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 81020
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15136817
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/136817 | TETRAZOLONES AS INHIBITORS OF FATTY ACID SYNTHASE | Apr 21, 2016 | Abandoned |
Array
(
[id] => 11336633
[patent_doc_number] => 20160362388
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-15
[patent_title] => 'CHEMILUMINESCENT METHODS AND REAGENTS FOR ANALYTE DETECTION'
[patent_app_type] => utility
[patent_app_number] => 15/133226
[patent_app_country] => US
[patent_app_date] => 2016-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 15786
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15133226
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/133226 | CHEMILUMINESCENT METHODS AND REAGENTS FOR ANALYTE DETECTION | Apr 19, 2016 | Abandoned |
Array
(
[id] => 15573931
[patent_doc_number] => 10577332
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-03-03
[patent_title] => Tetrazole derivatives
[patent_app_type] => utility
[patent_app_number] => 15/569349
[patent_app_country] => US
[patent_app_date] => 2016-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13290
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 42
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15569349
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/569349 | Tetrazole derivatives | Apr 18, 2016 | Issued |